|
|
|||
|
|
Robert (Robin) Bellas General Partner, Morgenthaler Ventures Robin has been responsible for Morgenthaler's investment in numerous health care and information technology companies that have completed public offerings or successful mergers. He is a Director of Ardian Medical, Cabochon Aesthetics, CareMedic, Ensure Medical, ForSight Labs, The Foundry, IPC-The Hospitalist Company, Satiety, Xtent and Wave7 Optics. In addition, he served as a Director or was actively involved with Arbor Health Care (AHCC) (acquired by Extendicare), Athena Neurosciences (ATHN) (acquired by Elan), CardioThoracic Systems (CTSI) (acquired by Guidant), Executone (XTON), Integrated Vascular Systems (acquired by Abbott Labs), The Liposome Company (LIPO) (acquired by Elan), LuMend (acquired by J&J), Managed Health Network (acquired by Foundation Health), Medaphis Corporation (MEDA), now PerSe (PSTI), National Medical Diagnostics (acquired by GE Medical), Perclose (PERC) (acquired by Abbott Labs), Sequana Therapeutics (SQNA) (acquired by Arris Pharmaceuticals), Surgical Health (acquired by HealthSouth), Thermage, VeriFone (VFIC) (acquired by Hewlett Packard), and Vical (VICL). Robin is a past Director of the Western Association of Venture Capitalists, and of the Stanford Business School Trust. Before Stanford, he served as a line officer on nuclear fast attack and ballistic missile submarines. Robin received a BS in Engineering from the United States Naval Academy (1966), and an MBA from the Stanford Graduate School of Business (1973). Robin and Terrye have two grown daughters and live in Portola Valley, California. He can be reached at | ||
| © 2007 Cierra Inc. | About Cierra | Products | For Clinicians | For Patients | News & Events | Contact Us | Home |
Cierra™ and PFx™ are trademarks of Cierra, Inc |